We exist to help PHI leaders foster clinical and business innovation.
ABOUT US
We proactively think about and analyse the key issues that PHI fund leaders don't have time to.
SERVICES
Our Services Include
Visual Commercial Perspectives
Entertaining and interactive deep data explorations parsing the challenges confronting PHI and appraising the the options vailable to PHI executives associated with resolving those problems for the betterment of their Fund and their fund's policyholders. Click here to see the releases schedule.
Customised Reports
Adapted from our established content library but crafted to meet the specific needs and situation of your fund. While the topics and data sets are in sync with our existing library, we fine-tune the data parameters to capture your Fund’s unique standpoint and we agree an appropriate narrative.
PHI Benchmarking Services
Commercial bio-markers and bird’s eye fund health checks. Use these services to identify and seize opportunities for performance augmentation.
Commercial Modelling Templates
- Benefit outlay reduction programs.
- Policholder growth investment pathways.
- Lifetime member valuation models.
Supply & demand imbalance heat-maps.
Our heatmaps visualise provider distribution relative to community demand. They color-codes area according to relative supply and demand balance so you can quickly ascertain relative access levels for you policyholders.
PHI Consulting Services Including
- Benefit outlay reduction audits.
- Optimal member growth pathways.
- Diversification outside of PHI strategy.
- Capital and investment asset advisory.
COMMERCIAL PANEL
The commercial panel develops all publications, data tools and models prepared by PHInsights
Dan Hilvert
Analytical Principal
Dan established PHInsigts with a desire to accelerate innovation in PHI. Dan has been a long-suffering believer in the potential for PHI to contribute much more to our healthcare system and believes the time is ripe for such innovation to occur. Dan has run a healthcare focussed corporate advisory firm over the past decade and in the decade prior, Dan ran Corporate Development for one of Australia’s leading health funds.
Sam Holt
Innovation Principal
Sam has established a series of healthcare ventures on behalf of top tier organisations including the Murdoch Children’s Research Institute, the Victorian Clinical Genetics Society and Medibank. Sam is also a passionate believer in the potential for PHI to deliver much more to Australian healthcare users.
Justin Begg
IT Systems Principal
Justin formerly an Associate Director in Healthcare and Health Payers at Accenture. Prior to that Justin was a GM in the DXC Technology Healthcare business, a leading global provider of Hospital, Pharmacy and other Healthcare and enterprise-wide Payer solutions (know Dedalus). Justin has also acted as strategic and technology adviser to two of Australia's leading health funds.
Matthew Moore
Operational Principal
Matthew has held CEO roles of two medium sized mutual PHI funds. He is an operational systems expert and also a fervent believer in the potential for PHI to deliver much more to Australian healthcare users.
CLINICAL PANEL
The Clinical Panel reviews benefit outlay reduction initiatives to gauge (a) clinical efficacy and (b) clinical implementation feasibility and (c) economic effectiveness
Clinical Panel recruitment underway, contact us for further information.